Research Advisory Committee on Gulf War Veterans' Illnesses
Research Update - August 2007
The following journal articles were distributed for review in August 2007. You can access the article's abstract by copying the paper title and pasting it into the search bar of the PubMed website, linked here.
Research Relevant to Gulf War Service and Exposures
1. Symptoms, ill-health and quality of life in a support group of Porton Down veterans. (Allender S, et al. Occup Med (Lond). Aug 2006; 56(5): 329-337)
2. Credibility of neuropsychological performances of Persian Gulf War veterans and military control subjects participating in clinical epidemiological research. (Barrash J, et al. Mil Med. Jul 2007; 172(7): 697-707)
3. Urinary isotopic analysis in the UK Armed Forces: No evidence of depleted uranium absorption in combat and other personnel in Iraq. (Bland DJ, et al. Occup Environ Med. Jul 3, 2007; [Epub ahead of print])
4. Guest editorial: Veterans Health Administration’s pain research portfolio and publications. (Elnitsky C, et al. J Rehabil Res Dev. 2007; 44(2): xi-xvii)
5. Chronic widespread pain in veterans of the first Gulf War: impact of deployment status and associated health effects. (Forman-Hoffman VL, et al. J Pain. Aug 17, 2007; [Epub ahead of print])
6. Twenty-four hour plasma control and adrenocorticotropic hormone in Gulf War veterans: relationships to posttraumatic stress disorder and health symptoms. (Golier JA, et al. Biol Psychiatry. Jul 3, 2007; [Epub ahead of print])
7. In the shadow of Iraq: posttraumatic stress disorder in 2007. (Greenburg DL, Roy MJ. J Gen Intern Med. Jun 2007; 22(6): 888-889)
8. Health and exposure concerns of veterans deployed to Iraq and Afghanistan. (Helmer DA, et al. J Occup Environ Med. May 2007; 49(5): 475-480)
9. A decade after the Tokyo sarin attack: a review of neurological follow-up of the victims. (Hoffman A, et al. Mil Med. Jun 2007; 172(6): 607-610)
10. Gulf War illness: lessons from medically unexplained symptoms. (Iversen A, et al. Clin Psychol Rev. Jul 17, 2007; [Epub ahead of print])
11. Neurotoxic potential of depleted uranium – effects in primary cortical neuron cultures and in Caenorhabditis elegans. (Jiang GC, et al. Toxicol Sci. Jul 16, 2007; [Epub ahead of print])
12. Guest editorial: research on pain and pain management in Veterans Health Administration: Promoting improved pain care for veterans through science and scholarship. (Kerns RD. J Rehabil Res Dev. 2007; 44(2): vii-x)
13. Post-traumatic stress disorder and depression in health care providers returning from deployment to Iraq and Afghanistan. (Kolkow TT, et al. Mil Med. May 2007; 172(5): 451-455)
14. Aging pathways for organophosphate inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry. (Li H, et al. Toxicol Sci Aug 13, 2007; [Epub ahead of print])
15. Latency and exposure-health associations in Gulf War veterans with early fatigue onsets: a case-control study. (Lucas KE, et al. Ann Epidemiol. Jul 25, 2007; [Epub ahead of print])
16. Subchronic intoxication with chlorfenvinphos, an organophosphate insecticide, affects rat brain antioxidative enzymes and glutathione level. (Lukaszewica-Hussain A. Food Chem Toxicol. Jul 14, 2007; [Epub ahead of print])
17. Animal models of chronic pesticide neurotoxicity. (Moser VC. Hum Exp Toxicol. Apr 2007; 26(4): 321-331)
18. Cholinergic status modulations in human volunteers under acute inflammation. (Ofek K, et al. J Mol Med. Jul 27, 2007; [Epub ahead of print])
19. Serological evidence of arboviral infection and self-reported febrile illness among U.S. troops deployed to Al Asad, Iraq. (Riddle MS, et al. Epidemiol Infect. Jun 25, 2007; 1-5 [Epub ahead of print])
20. Mental health consequences of overstretch in the UK armed forces: first phase of a cohort study. (Rona RJ, et al. BMJ. Jul 30, 2007; [Epub ahead of print])
21. Lessons learned from smallpox vaccination of U.S. Navy forces before Operation Iraqi Freedom. (Savitz S, Stewart J. Mil Med. Apr 2007; 172(4): 353-358)
22. The occupational role of women in military service: Validation of occupation and prevalence of exposures in the Millennium Cohort Study. (Smith TC, et al. Int J Environ Health Res. Aug 2007; 17(4): 271-284)
23. Multi-drug resistant Acinetobacter infections in critically injured Canadian Forces soldiers. (Tien HC, et al. BMC Infect Dis. Aug 14, 2007; 7(1): 95 [Epub ahead of print])
Research on Evaluation/Treatment of Chronic Multisymptom Illnesses
1. Management of patients with fibromyalgia using biofeedback: A randomized control trial. (Babu AS , et al. Indian J Med Sci Aug 2007; 61(8): 455-461)
2. Introduction to the special issue on medically unexplained symptoms: background and future directions. (Brown RJ. Clin Psychol Rev. Jul 17, 2007; [Epub ahead of print])
3. The genetics of fibromyalgia syndrome. (Buskila D, et al. Pharmacogenomics. Jan 2007; 8(1): 67-74)
4. A twin study of cognitive function in chronic fatigue syndrome: the effects of sudden illness onset. (Claypoole KH, et al. Neuropsychology. Jul 2007; 21(4): 507-513)
5. Pharmacological treatment of fibromyalgia and other chronic musculoskeletal pain. (Goldenberg DL. Best Pract Res Clin Rheumatol. Jun 2007; 21(3): 499-511)
6. Chronic fatigue syndrome treated by acupuncture and moxibustion in combination with psychological approaches in 310 cases. (Guo J. J Tradit Chin Med. Jun 2007; 27(2): 92-95)
7. Serum serotonin levels are not useful in diagnosing fibromyalgia. (Jaschko G, et al. Ann Rheum Dis. Sep 2007; 66(9): 1267-1268)
8. Skin biopsy findings: implications for the pathophysiology of fibromyalgia. (Kim SH. Med Hypotheses. 2007; 69(1): 141-144)
9. Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome. (Maes M, et al. Neuro Endocrinol Lett Jul 11, 2007; 28(4) [Epub ahead of print])
10. Not in the mind of neurasthenic lazybones but in the cell nucleus: patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta. (Maes M, et al. Neuro Endocrinol Lett. Jul 11, 2007; 28(4) [Epub ahead of print])
11. Non-pharmacological treatment of chronic widespread musculoskeletal pain. (Mannerkorpi K, Henriksson C. Best Pract Res Clin Rheumatol. Jun 2007; 21(3): 513-534)
12. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells. (Mihaylova I, et al. Neuro Endocrinol Lett. Jul 11, 2007; 28(4) [Epub ahead of print])
13. Symptoms of autonomic dysfunction in chronic fatigue syndrome. (Newton JL, et al. QJM. Jul 7, 2007; [Epub ahead of print])
14. Hematologic and urinary excretion anomalies in patients with chronic fatigue syndrome. (Niblett SH, et al. Exp Biol Med (Maywood ). Sep 2007; 232(8): 1041-1049)
15. Treatment of fibromyalgia and its symptoms. (Staud R. Expert Opin Pharmacother. Aug 2007; 8(11): 1629-1642)
16. Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome. (Van Den Eede F, et al. Neuropsychobiology. Jun 27, 2007; 112-120 [Epub ahead of print])
17. Fibromyalgia patients show an abnormal dopamine response to pain. (Wood PB, et al. Eur J Neurosci. Jun 2007; 25(12): 3576-3582)
18. A real-time assessment of the effect of exercise in chronic fatigue syndrome. (Yoshiuchi K, et al. Physiol Behav. Jul 24, 2007; [Epub ahead of print])
19. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. (Yunus MB . Semin Arthritis Rheum. Jun 2007; 36(6): 339-356)
20. Role of central sensitization in symptoms beyond muscle pain, and the evaluation of a patient with widespread pain. (Yunus MB . Best Pract Res Clin Rheumatol. Jun 2007; 21(3): 481-497)
